Friday, March 15, 2019 1:35:58 PM
Story Here
How this relates to Invitro:
InVitro International is a pioneer in the development and application of proprietary non-animal testing alternatives for the determination of eye irritation, skin irritation and skin toxicity. The Company develops and markets in vitro assay kits and systems to detect, rank, and predict the potential level of irritancy, toxicity or corrosivity of substances to human eye and/or skin tissue. An “in vitro” assay measures a substance of clinical interest without the use of live animals or animal tissue. The results may be either qualitative, as in “yes/no”, or quantitative, as in measuring the impact of a particular substance in a tested sample.
FEATURED Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • Mar 18, 2024 8:51 AM
FEATURED Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation • Mar 18, 2024 8:09 AM
Greenlite Ventures Enters into Strategic Alliance with Woodway USA • GRNL • Mar 15, 2024 4:00 PM
HealthLynked Welcomes David Rosal as New Chief Financial Officer • HLYK • Mar 13, 2024 8:00 AM
ECGI Holdings, Inc. Announces Continued Efforts in Financial Optimization • ECGI • Mar 13, 2024 8:00 AM
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • PSYC • Mar 13, 2024 7:13 AM